NCT06429631

Brief Summary

Neurogenic bladder is a condition that occurs due to nerve damage or congenital problems and causes urination disorders. Nowadays, in individuals diagnosed with neurogenic bladder, Clean Intermittent Catheterization is often used to evacuate the urine accumulated in the bladder. Clean Intermittent Catheterization(CIC) is a simple, safe and effective method in which the catheter is placed through the meatus. In this application, the catheter is removed without waiting after urine drainage is achieved. This process is usually performed on its own. Since IC(Intermittent Catheterization) is a procedure performed on the bladder, it may cause some complications. IC application must be performed successfully to prevent or reduce complications. The success of the technique largely depends on patient education and follow-up. Sometimes patients may not be able to come to the hospital for follow-up and feedback after IC training. Innovations are needed to ensure the continuation of distance education so that the education of patients who cannot come to the hospital is not incomplete. The literature includes brochures, videos, websites and some mobile applications for IC training. However, no application has been found that monitors patients' urine amounts. This research was planned to examine the effect of clean intermittent catheterization training given via mobile application to individuals with spinal cord injury on their quality of life and compliance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2023

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

May 18, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 28, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 15, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2024

Completed
Last Updated

March 6, 2025

Status Verified

March 1, 2025

Enrollment Period

1 year

First QC Date

May 18, 2024

Last Update Submit

March 3, 2025

Conditions

Keywords

neurogenic bladdereducationmobil applicationcompliancequality of life

Outcome Measures

Primary Outcomes (2)

  • 1. WHOQOL-BREF(World Health Organization Quality of Life questionnaire),

    This study want to evaluate quality of life with 2 scales. WHOQOL-BREF(World Health Organization Quality of Life Scale):The WHO Quality of Life Assessment (WHOQOL) is a generic quality of life instrument that was designed to be applicable to people living under different circumstances, conditions, and cultures. The short version known as WHOQOL-BREF with 26 items. Turkish version is 27 items. It is based on a Likert-type scale and is scored from 1 to 5, with higher scores indicating a better quality of life.

    Patients fill the scale "before discharge" and 12 weeks after discharge.

  • 2. Intermittent Self-Catheterization Questionnaire (ISC-Q)

    This is a 24-item self-administered questionnaire. Each item is scored on a 5-point Likert-type scale ranging from 0 (strongly disagree) to 4 (strongly agree), and after the conversion of the 14 reverse-coded items to give a common range of 0-100, the scores are calculated by multiplying the mean value of all items within each domain by 25. The total ISC-Q score is then calculated from the simple average from across the four domains (0-100), with higher scores indicating a higher quality of life.

    Patients fill the scale "before discharge" and 12 weeks after discharge.

Secondary Outcomes (1)

  • Intermittent Catheterization Adherence Scale (ICAS)

    Patients fill the scale "before discharge" and 12 weeks after discharge.

Other Outcomes (1)

  • Mobile Application Usability Scale (MAUS)

    Only the experimental group completes this scale 12 weeks after discharge.

Study Arms (2)

control group(routine CIC education)

NO INTERVENTION

This group has routine CIC education. They fill the scales before discharge and 12. week after discharge.

experimental group(routine CIC education+mobile application on telephone)

EXPERIMENTAL

This group has routine CIC education. Also mobile application uploaded their telephone before discharge. They fill the scales before discharge and 12. week after discharge.

Device: mobile application on telephone

Interventions

when patient discharge from the hospital, mobile application downloaded their telephone. then researcher give feedback about patients CIC outputs. also mobile application include 2 animations, videos, "frequently asked questions" and "ask the expert" section.

experimental group(routine CIC education+mobile application on telephone)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants were excluded if (1) they wanted to withdraw from the study, (2) they did not complete the data collection forms, (3) the doctor decided they should stop CIC, (4) they did not use the mobile application in the intervention group, and (5) they had received CIC training more than one month ago.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ankara Gaziler Physical Therapy and Rehabilitation Training and Research Hospital

Ankara, Çankaya, 0000000, Turkey (Türkiye)

Location

Ankara Gaziler Physical Therapy and Rehabilitation Training and Research Hospital

Ankara, Çankaya, 680000, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Urinary Bladder, NeurogenicSpinal Cord InjuriesPatient Compliance

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal Cord DiseasesCentral Nervous System DiseasesTrauma, Nervous SystemWounds and InjuriesPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • NURCAN ÇALIŞKAN, Prof. Dr

    Gazi University

    PRINCIPAL INVESTIGATOR
  • BİLGE YILMAZ, Prof. Dr.

    SBÜ GAZİLER FİZİK TEDAVİ VE REHABİLİTASYON EĞİTİM VE ARAŞTIRMA HASTANESİ

    PRINCIPAL INVESTIGATOR
  • Nilgün Aras, Phd student

    SBÜ GAZİLER FİZİK TEDAVİ VE REHABİLİTASYON EĞİTİM VE ARAŞTIRMA HASTANESİ

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The person doing the statistical analysis will not know which is the experiment and which is the control group.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: parallel group single-blind randomized control trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Nurse, RN, MSN, Phd

Study Record Dates

First Submitted

May 18, 2024

First Posted

May 28, 2024

Study Start

August 1, 2023

Primary Completion

August 15, 2024

Study Completion

November 15, 2024

Last Updated

March 6, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Since the study is still not finished, it was decided not to share it.

Locations